BUSINESS● LOWSep 22 · Sep 22, 2026, 12:02 PM
Viking Therapeutics soars after trial data for obesity drug
Seeking Alpha Tech · global
Viking Therapeutics' stock has risen significantly following the release of positive trial data for its obesity drug. This indicates a favorable market reaction to the company's pharmaceutical development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS31m agoMicrosoft is the only hyperscaler not forecast to dip into negative FCF in the next yearSeeking Alpha TechBUSINESS34m agoRegions expects Q4 2026 net interest income up 1%-2% as deposit platform conversion targets mid-2027Seeking Alpha Tech